Literature DB >> 4179303

Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies.

A Pinchera, P Liberti, E Martino, G F Fenzi, L Grasso, L Rovis, L Baschieri, G Doria.   

Abstract

Mesh：

Substances：

Year:  1969        PMID： 4179303     DOI： 10.1210/jcem-29-2-231

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  26 in total

1.  Radioiodine is an effective, inexpensive, and safe treatment for Graves' hyperthyroidism, its immunological effects must be taken into account.

Authors:  L Chiovato; R Rocchi; E Fiore
Journal:  J Endocrinol Invest       Date:  1999-04       Impact factor: 4.256

2.  Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.

Authors:  F A Karlsson; T H Tötterman
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

3.  Graves' disease and Hashimoto's thyroiditis: effects of high doses of antithyroid drugs on thyroid autoantibody levels.

Authors:  J H Romaldini; M C Werner; H F Rodrigues; V L Teixeira; R S Werner; C S Farah; N Bromberg
Journal:  J Endocrinol Invest       Date:  1986-06       Impact factor: 4.256

4.  Treatment of thyrotoxicosis.

Authors:  R S Swerdloff
Journal:  Calif Med       Date:  1970-08

5.  Recurrent thyrotoxicosis after subtotal thyroidectomy.

Authors:  A J Hedley; I P Ross; J S Beck; D Donald; F Albert-Recht; W Michie; J Crooks
Journal:  Br Med J       Date:  1971-10-30

6.  Quantification of cells expressing the thyrotropin receptor in extraocular muscles in thyroid associated orbitopathy.

Authors:  A Boschi; Ch Daumerie; M Spiritus; C Beguin; M Senou; D Yuksel; M Duplicy; S Costagliola; M Ludgate; M C Many
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

7.  The presence of higher levels of thyroglobulin, but not thyroid autoantibodies, in the thyroid vein in Graves' disease.

Authors:  F F Chou; P W Wang; S M Sheen-Chen
Journal:  J Endocrinol Invest       Date:  1994-01       Impact factor: 4.256

8.  Are antithyroid drugs immunosuppressive?

Authors:  P Kendall-Taylor
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-18

9.  Syndrome of persisting thyroid stimulating immunoglobulins and growth promotion of goiter combined with low thyroxine and high triiodothyronine serum levels in drug treated Graves' disease.

Authors:  K W Wenzel; J R Lente
Journal:  J Endocrinol Invest       Date:  1983-10       Impact factor: 4.256

10.  Antithyroid drug and Graves' hyperthyroidism. Significance of treatment duration and TRAb determination on lasting remission.

Authors:  R V García-Mayor; C Páramo; R Luna Cano; L F Pérez Mendez; J C Galofré; A Andrade
Journal:  J Endocrinol Invest       Date:  1992-12       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.